Brief: Bellicum Pharmaceuticals Reports First Quarter 2019 Financial Results And Provides Operational Update
07/05/2019 12:37
May 7 (Reuters) - Bellicum Pharmaceuticals Inc BLCM.O :
* BELLICUM PHARMACEUTICALS REPORTS FIRST QUARTER 2019
FINANCIAL
RESULTS AND PROVIDES OPERATIONAL UPDATE
* BELLICUM PHARMACEUTICALS INC - BELLICUM REPORTED CASH,
RESTRICTED CASH AND INVESTMENTS TOTALING $78.1 MILLION AS OF
MARCH 31, 2019
* BELLICUM PHARMACEUTICALS INC - EXPECTS THAT CURRENT CASH
RESOURCES WILL BE SUFFICIENT TO MEET OPERATING REQUIREMENTS
THROUGH END OF 2019
* BELLICUM PHARMACEUTICALS INC - QTRLY NET LOSS PER SHARE
ATTRIBUTABLE TO COMMON SHAREHOLDERS, BASIC AND DILUTED $0.55
Source text for Eikon: ID:nGNX8R9TYV
Further company coverage: BLCM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bellicum Pharmaceuticals
See all newsBrief: Bellicum Pharmaceuticals- In Connection With Dissolution And Plan Of Dissolution, On February 23, Richard A. Fair Resigned As President And Co's CEO
Brief: Bellicum Pharmaceuticals Says Board Approved Liquidation And Dissolution Of Co In Connection With Approval Of Asset Purchase Agreement
Brief: Bellicum Pharmaceuticals Initiated A 12 Stock Split On Dec 8, 2022
Brief: Bellicum Reports Third Quarter 2022 Financial Results And Provides Operational Update
Bellicum Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview